Search
for

    Glossary TNF inhibitors

    medications that block inflammation-causing proteins in autoimmune diseases

    TNF inhibitors, also known as Tumor Necrosis Factor inhibitors or TNF blockers, are medications that reduce inflammation by blocking the activity of TNF-alpha, a substance in the body that causes inflammation and can lead to immune system diseases. They are commonly used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease by preventing the immune system from attacking healthy tissues.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold Dermatology Online Journal · 2017 · 9 citations
    2. TNF‐inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy Journal of cutaneous pathology · 2017 · 20 citations
    3. TNF-α Inhibitor-Induced Psoriasis and Psoriatic Alopecia in Adolescent with Ulcerative Colitis: Clinical Case Вопросы современной педиатрии · 2023 · 3 citations
    4. Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors InTech eBooks · 2018 · 2 citations
    5. The development of universal alopecia during therapy with TNF-α inhibitors in patients with ankylosing spondylitis: description of three cases Rheumatology Science and Practice · 2021
    6. Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women BMC women's health · 2023 · 2 citations
    7. Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals Carcinogenesis · 2015 · 11 citations
    8. Lessons from TNF-α Inhibitor–Induced Alopecia Areata: Does TNF-α Operate as a Hair Follicle Immune Privilege Guardian under Inflammatory Conditions? Journal of Investigative Dermatology · 2025 · 2 citations
    9. Cardamonin inhibits the expression of inflammatory mediators in TNF-α-stimulated human periodontal ligament cells Immunopharmacology and Immunotoxicology · 2024 · 3 citations
    10. 0248 Risk of infections in patients with hidradenitis suppurativa treated with TNF-α inhibitors vs. IL-17 inhibitors: A large-scale cohort study Journal of Investigative Dermatology · 2025
    11. Hinokitiol, a Natural Tropolone Derivative, Inhibits TNF-α Production in LPS-Activated Macrophages via Suppression of NF-κB Planta Medica · 2008 · 54 citations
    12. 64750 Which lessons on the role of TNF-a in hair follicle (patho-)biology can be learned from TNF-a inhibitor-induced alopecia areata? Journal of the American Academy of Dermatology · 2025
    13. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review Frontiers in medicine · 2023 · 2 citations
    14. Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review PloS one · 2024
    15. Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review Dermatology and Therapy · 2026
    16. Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review Archives of Dermatological Research · 2025 · 3 citations
    17. A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment Orphanet Journal of Rare Diseases · 2025
    18. Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers Annals of Dermatology · 2011 · 3 citations
    19. Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition Journal of Dermatological Treatment · 2026 · 1 citations
    20. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease Alimentary Pharmacology & Therapeutics · 2013 · 60 citations
    21. Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors Journal of clinical and investigative dermatology · 2014 · 2 citations
    22. Psoriatic Alopecia in a Patient With Crohn Disease: An Uncommon Manifestation of Tumor Necrosis Factor α Inhibitors Cutis · 2021
    23. Tumor necrosis factor α inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature Archives of Dermatological Research · 2025 · 3 citations
    24. P07 Pityriasis amiantacea: a unique presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy Rheumatology advances in practice · 2023 · 1 citations
    25. Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia) Informa Healthcare eBooks · 2012 · 1 citations
    26. TNF-a in nonscarring inflammatory alopecia Journal of The American Academy of Dermatology · 2014
    27. - Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia) CRC Press eBooks · 2012
    28. Trichorrhexis nodosa: a distinctive presentation after tumour necrosis factor-α inhibitor therapy Clinical and Experimental Dermatology · 2015 · 10 citations
    29. Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia) Informa Healthcare eBooks · 2012
    30. 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes Journal of Investigative Dermatology · 2003 · 56 citations